A detailed history of Smartleaf Asset Management LLC transactions in Biogen Inc. stock. As of the latest transaction made, Smartleaf Asset Management LLC holds 419 shares of BIIB stock, worth $66,968. This represents 0.01% of its overall portfolio holdings.

Number of Shares
419
Previous 147 185.03%
Holding current value
$66,968
Previous $33.6 Million 142.91%
% of portfolio
0.01%
Previous 0.01%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$189.07 - $236.8 $51,427 - $64,409
272 Added 185.03%
419 $81.7 Million
Q2 2024

Aug 13, 2024

BUY
$190.52 - $236.72 $11,431 - $14,203
60 Added 68.97%
147 $33.6 Million
Q1 2024

Oct 07, 2024

SELL
$212.02 - $267.71 $12,721 - $16,062
-60 Reduced 40.82%
87 $18.8 Million
Q1 2024

May 02, 2024

BUY
$212.02 - $267.71 $14,205 - $17,936
67 Added 335.0%
87 $3.65 Million
Q4 2023

Feb 12, 2024

BUY
$222.59 - $267.94 $4,451 - $5,358
20 New
20 $5.21 Million

Others Institutions Holding BIIB

About BIOGEN INC.


  • Ticker BIIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 144,000,992
  • Market Cap $23B
  • Description
  • Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...
More about BIIB
Track This Portfolio

Track Smartleaf Asset Management LLC Portfolio

Follow Smartleaf Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Smartleaf Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Smartleaf Asset Management LLC with notifications on news.